Researchers at UT Austin and UT MD Anderson say an experimental chemotherapy drug prompts cancer cells to mimic viral infections, triggering an immune response that attacks tumors and may reduce the need for higher chemo doses.
About the Author
Discover more from USA NEWS
Subscribe to get the latest posts sent to your email.
